½ÃÀ庸°í¼­
»óǰÄÚµå
1270510

¼¼°èÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå º¸°í¼­(2023³â)

High Performance Medical Plastics Global Market Report 2023

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Business Research Company | ÆäÀÌÁö Á¤º¸: ¿µ¹® 250 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

°í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ¼¼°è ½ÃÀåÀº 2022³â 8¾ï 9,000¸¸ ´Þ·¯¿¡¼­ 2023³â¿¡´Â 9¾ï 6,000¸¸ ´Þ·¯·Î, CAGR 7.9%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ·¯½Ã¾Æ¡¤¿ìÅ©¶óÀ̳ª ÀüÀïÀº Àû¾îµµ ´Ü±âÀûÀ¸·Î´Â COVID-19 ÆÒµ¥¹ÍÀ¸·ÎºÎÅÍÀÇ ¼¼°è °æÁ¦ ȸº¹ °¡´É¼ºÀ» È¥¶õ½ÃÄ×½À´Ï´Ù. ÀÌ ¾ç±¹ °£ÀÇ ÀüÀïÀº ´Ù¼öÀÇ ±¹°¡¿¡ ´ëÇÑ °æÁ¦ Á¦Àç, »óǰ °¡°Ý ±Þµî, °ø±Þ¸Á È¥¶õÀ¸·Î À̾îÁö°í, »óǰÀ̳ª ¼­ºñ½º Àüü¿¡ ÀÎÇ÷¹À̼ÇÀ» À¯¹ßÇÏ¿© ¼¼°èÀÇ ¸¹Àº ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀåÀº CAGR 7.8%·Î 2027³â¿¡´Â 13¾ï ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

2022³â °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå¿¡¼­´Â ºÏ¹Ì°¡ ÃÖ´ë Áö¿ªÀÌ µÇ¾ú½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø±â°£ Áß °¡Àå ºü¸£°Ô ¼ºÀåÇÏ´Â Áö¿ªÀÌ µÉ Àü¸ÁÀÔ´Ï´Ù. °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå º¸°í¼­ ´ë»ó Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ¼­À¯·´, µ¿À¯·´, ºÏ¹Ì, ³²¹Ì, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù.

½ÅÈï±¹ÀÇ ÀÇ·áºñ ÁöÃâ Áõ°¡´Â ÇâÈÄ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Àεµ, Áß±¹ µî ½ÅÈï±¹µéÀº ÀÇ·á ÀÎÇÁ¶ó ±¸Ãà, °øÁߺ¸°Ç °³¼±, ÃÖ±Ù Äڷγª19 ÆÒµ¥¹ÍÀ¸·Î ÀÎÇÑ Çʿ伺À¸·Î ÀÎÇØ ÀÇ·á ÁöÃâÀ» ´Ã¸®°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÁöÃâ Áõ°¡·Î ÀÎÇØ »ç¶÷µéÀº °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½À¸·Î ¸¸µç ÀÓÇöõÆ® ¹× º¸Ã¶ ½Ã¼úÀ» ¹ÞÀ» ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ±× °á°ú, ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ÀÇ »ç¿ë·®ÀÌ Áõ°¡ÇÏ¿© °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, Àεµ¿¡ º»»ç¸¦ µÐ Á¤ºÎ ¼öÃâ ÁøÈï ±â°üÀÎ IBEF(Indian Brand Equity Foundation)¿¡ µû¸£¸é, ÀεµÀÇ °ø°ø ÀÇ·áºñ´Â 2020-21³â GDP ´ëºñ 1.8%¿¡¼­ 2021-22³â 2.1%·Î Áõ°¡ÇßÀ¸¸ç, 2021³â ±âÁØ 470¸¸ ¸íÀÇ ±Ù·ÎÀÚ¸¦ °í¿ëÇÏ°í ¶ÇÇÑ, The Ministry of Health and Family Welfare´Â 2022-23³â ¿¬¹æ ¿¹»ê¿¡¼­ 86,200.65Å©·Î(112¾ï 8,000¸¸ ´Þ·¯)¸¦ Áö¿ø¹Þ½À´Ï´Ù. µû¶ó¼­ ½ÅÈï±¹ÀÇ ÀÇ·áºñ Áõ°¡´Â °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå Æ¯Â¡

Á¦3Àå °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå - °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

  • COVID-19¿¡ ÀÇÇÑ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå¿¡ ´ëÇÑ ¿µÇâ
  • ¿ìÅ©¶óÀ̳ª¡¤·¯½Ã¾Æ ÀüÀïÀÌ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ
  • °íÀÎÇ÷¹À̼ÇÀÌ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ

Á¦5Àå °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå ±Ô¸ð¿Í ¼ºÀå

  • ¼¼°èÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå ½ÇÀû, 2017-2022³â
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ¼¼°èÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå ¿¹Ãø, 2022-2027F, 2032F
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ

Á¦6Àå °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå ¼¼ºÐÈ­

  • ¼¼°èÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ºÒ¼Ò¼öÁö(FP)
  • °í¼º´É Æú¸®¾Æ¹Ìµå(HPPA)
  • Æú¸®¾Æ¸±¿¡Å׸£ÄÉÅæ(PAEK)
  • Æú¸®Æä´Ò·» ¼³ÆÄÀ̵å(PPS)
  • Æú¸®¿¡Å׸£À̵̹å(PEI)
  • ±âŸ À¯Çü
  • ¼¼°èÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, ¿øÀç·áº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Æú¸®Ä«º¸³×ÀÌÆ®
  • Æú¸®ÇÁ·ÎÇÊ·»
  • Æú¸®¼³Æù
  • Æú¸®Åׯ®¶óÇ÷ç¿À·Î¿¡Æ¿·»
  • Æú¸®Æä´Ò·» ¼³ÆÄÀ̵å
  • ±âŸ ¿øÀç·á
  • ¼¼°èÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ÀÇ·á±â±â¿Í Åø
  • ÀÇ·á¿ëǰ
  • ¾à¹°Àü´Þ
  • º¸Çü¹°°ú ÀÓÇöõÆ®
  • Ä¡·á ½Ã½ºÅÛ
  • ±âŸ ¿ëµµ

Á¦7Àå °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå Áö¿ª ¹× ±¹°¡ ºÐ¼®

  • ¼¼°èÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, Áö¿ªº°, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¼¼°èÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, ±¹°¡º°, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå

  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå °³¿ä
  • Áö¿ª Á¤º¸, COVID-19ÁõÀÇ ¿µÇâ, ½ÃÀå Á¤º¸, ¹è°æ Á¤º¸, Á¤ºÎ ´ëó, ±ÔÁ¦, ±ÔÁ¦±â°ü, ÁÖ¿ä ´Üü, °ú¼¼¾×, ¹ýÀμ¼ ±¸Á¶, ÅõÀÚ, ÁÖ¿ä ±â¾÷
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦9Àå Áß±¹ÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå

  • Áß±¹ÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå °³¿ä
  • Áß±¹ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Áß±¹ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦10Àå ÀεµÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå

  • ÀεµÀÇ °í¼º´É ÀÇ·á ÇÃ¶ó½ºÆ½ ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ÀεµÀÇ °í¼º´É ÀÇ·á ÇÃ¶ó½ºÆ½ ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦11Àå ÀϺ»ÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå

  • ÀϺ»ÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ÀϺ»ÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦12Àå È£ÁÖÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå

  • È£ÁÖÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • È£ÁÖÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦13Àå Àεµ³×½Ã¾ÆÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå

  • Àεµ³×½Ã¾ÆÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Àεµ³×½Ã¾ÆÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦14Àå Çѱ¹ÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå

  • Çѱ¹ÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Çѱ¹ÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦15Àå ¼­À¯·´ÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå

  • ¼­À¯·´ÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå °³¿ä
  • ¼­À¯·´ÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¼­À¯·´ÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦16Àå ¿µ±¹ÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå

  • ¿µ±¹ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¿µ±¹ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦17Àå µ¶ÀÏÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå

  • µ¶ÀÏÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • µ¶ÀÏÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦18Àå ÇÁ¶û½ºÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå

  • ÇÁ¶û½ºÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ÇÁ¶û½ºÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦19Àå µ¿À¯·´ÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå

  • µ¿À¯·´ÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå °³¿ä
  • µ¿À¯·´ÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • µ¿À¯·´ÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦20Àå ·¯½Ã¾ÆÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå

  • ·¯½Ã¾ÆÀÇ °í¼º´É ÀÇ·á ÇÃ¶ó½ºÆ½ ½ÃÀå, Á¾·ùº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ·¯½Ã¾ÆÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦21Àå ºÏ¹ÌÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå

  • ºÏ¹ÌÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå °³¿ä
  • ºÏ¹Ì °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ºÏ¹Ì °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦22Àå ¹Ì±¹ÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå

  • ¹Ì±¹ÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå °³¿ä
  • ¹Ì±¹ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¹Ì±¹ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦23Àå ³²¹ÌÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå

  • ³²¹Ì °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå °³¿ä
  • ³²¹Ì °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ³²¹Ì °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦24Àå ºê¶óÁúÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå

  • ºê¶óÁúÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ºê¶óÁúÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦25Àå Áßµ¿ÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå

  • Áßµ¿ÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå °³¿ä
  • Áßµ¿ÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Áßµ¿ÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦26Àå ¾ÆÇÁ¸®Ä«ÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå

  • ¾ÆÇÁ¸®Ä«ÀÇ °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå °³¿ä
  • ¾ÆÇÁ¸®Ä«ÀÇ °í¼º´É ÀÇ·á ÇÃ¶ó½ºÆ½ ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¾ÆÇÁ¸®Ä«ÀÇ °í¼º´É ÀÇ·á ÇÃ¶ó½ºÆ½ ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦27Àå °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå °æÀï »óȲ°ú ±â¾÷ °³¿ä

  • °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå °æÀï »óȲ
  • °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå ±â¾÷ °³¿ä
    • Solvay SA
    • SABIC
    • Mitsubishi Chemical Corporation
    • Evonik Industries AG
    • Arkema SA

Á¦28Àå °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀåÀÇ ÁÖ¿ä ÀμöÇÕº´

Á¦29Àå °í¼º´É ÀÇ·á¿ë ÇÃ¶ó½ºÆ½ ½ÃÀå ÇâÈÄ Àü¸Á°ú °¡´É¼º ºÐ¼®

Á¦30Àå ºÎ·Ï

KSM 23.05.19

“High Performance Medical Plastics Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on high performance medical plastics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for high performance medical plastics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The high performance medical plastics market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Fluoropolymers (FP); High Performance Polyamides (HPPA); Polyaryletherketones (PAEK); Polyphenylene Sulfides (PPS); Polyetherimide (PEI); Other Types
  • 2) By Raw Material: Polycarbonate; Polypropylene; Polysulfone; Polytetrafluoroethylene; Polyphenylene sulfide; Other Raw Materials
  • 3) By Application: Medical Equipment and Tools; Medical Supplies; Drug Delivery; Prosthesis and Implants; Therapeutic System; Other Apllications
  • Companies Mentioned: Solvay SA; SABIC; Mitsubishi Chemical Corporation; Evonik Industries AG; Arkema SA
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the high performance medical plastics market are Solvay SA, SABIC, Mitsubishi Chemical Corporation, Evonik Industries AG, Arkema SA, Ensinger GmbH, Victrex PLC., Rochling SE & Co. AG, Raumedic AG, The Chemours Company, DuPont de Nemours Inc., HTI Plastics, C&J Industries Inc., Metro Mold and Design, and AMS Micro Medical LLC.

The global high performance medical plastics market is expected to grow from $0.89 billion in 2022 to $0.96 billion in 2023 at a compound annual growth rate (CAGR) of 7.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The high performance medical plastics market is expected to grow to $1.30 billion in 2027 at a CAGR of 7.8%.

The high-performance medical plastics market consists of sales of polyether ether ketone (PEEK), and fluorinated ethylene propylene. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

High-performance medical plastics are plastics that have high temperature and chemical resistance, biocompatibility, low friction, chemical inertness, and radiation resistance which makes them ideal for medical uses in medical devices and Equipment. They are appropriate for use in a variety of medical devices and equipment due to their special properties, which include biocompatibility, low friction, chemical inertness, non-porosity, and radiation resistance. They are used to make various pumps and valves, medical devices, lab instruments, implants, etc.

North America was the largest region in the high performance medical plastics market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high performance medical plastics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The major types of high performance medical plastics are fluoropolymers (fp), high performance polyamides (hppa), polyaryletherketones (paek), polyphenylene sulfides (pps), polyetherimide (pei), and others. Fluoropolymers are fluorocarbon-based polymers with strong carbon-fluoride bonds. They have high rigidity and strength. The various types of raw materials used are polycarbonate, polypropylene, polysulfone, polytetrafluoroethylene, polyphenylene sulfide, and others that are used in various applications such as medical equipment and tools, medical supplies, drug delivery, prosthesis and implants, therapeutic system and others.

Growing healthcare expenditure in emerging economies is expected to propel the growth of the high-performance medical plastics market going forward. Emerging economies such as India and China are increasing their spending on healthcare due to the need to improve healthcare infrastructure, improve public health and the recent COVID-19 pandemic. Increased spending allows the population to go for implants and prosthetic procedures which are made from high-performance medical plastics. This in turn increases the use of medical plastics which drives the high-performance medical plastics market forward. For instance, according to IBEF (Indian Brand Equity Foundation), an India-based government export promotion agency, India's public healthcare spending increased from 1.8% of GDP in 2020-21 to 2.1% in 2021-22. With 4.7 million workers as of 2021, Also, The Ministry of Health and Family Welfare received Rs. 86,200.65 crores (US$ 11.28 billion) from the Union Budget 2022-23. Therefore, the growing health expenditure in emerging economies is driving the growth of the High-performance medical plastics market.

Technological advancement is a key trend gaining popularity in the high-performance medical plastics market. Major companies operating in the high-performance medical plastics market are constantly focused on developing technologically advanced products to strengthen their market position. For instance, in July 2020, Evonik, a Germany-based specialty chemicals company, launched the world's first 3D-printable polyether ether ketone (PEEK) filament which is based on VESTAKEEP i4 G, a highly viscous, high-performance polymer. The new filament is launched under the name VESTAKEEP i4 3DF and it is biocompatible for making implants due to its strength and rigidity. The filament is also X-ray transparent and bio-stable. It is produced under clean room conditions and maintained for high medical quality standards.

In December 2021, Material & Design Solutions (MDS), a US-based sealing component provider for high temperature and pressure environments acquired the assets of APS Plastics and Manufacturing for an undisclosed amount. The acquisition includes extensive machining capabilities that will allow MDS to shift from resins to finished components business and to be more competitive in terms of pricing. APS Plastics and Manufacturing is a US-based manufacturer of custom plastic, metal, and components for medical as well as other industries.

The countries covered in the high performance medical plastics market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The high performance medical plastics market research report is one of a series of new reports from The Business Research Company that provides high performance medical plastics market statistics, including high performance medical plastics industry global market size, regional shares, competitors with a high performance medical plastics market share, detailed high performance medical plastics market segments, market trends and opportunities, and any further data you may need to thrive in the high performance medical plastics industry. This high performance medical plastics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Table of Contents

1. Executive Summary

2. High Performance Medical Plastics Market Characteristics

3. High Performance Medical Plastics Market Trends And Strategies

4. High Performance Medical Plastics Market - Macro Economic Scenario

  • 4.1. COVID-19 Impact On High Performance Medical Plastics Market
  • 4.2. Ukraine-Russia War Impact On High Performance Medical Plastics Market
  • 4.3. Impact Of High Inflation On High Performance Medical Plastics Market

5. High Performance Medical Plastics Market Size And Growth

  • 5.1. Global High Performance Medical Plastics Historic Market, 2017-2022, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global High Performance Medical Plastics Forecast Market, 2022-2027F, 2032F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. High Performance Medical Plastics Market Segmentation

  • 6.1. Global High Performance Medical Plastics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Fluoropolymers (FP)
  • High Performance Polyamides (HPPA)
  • Polyaryletherketones (PAEK)
  • Polyphenylene Sulfides (PPS)
  • Polyetherimide (PEI)
  • Other Types
  • 6.2. Global High Performance Medical Plastics Market, Segmentation By Raw Material, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Polycarbonate
  • Polypropylene
  • Polysulfone
  • Polytetrafluoroethylene
  • Polyphenylene sulfide
  • Other Raw Materials
  • 6.3. Global High Performance Medical Plastics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Medical Equipment And Tools
  • Medical Supplies
  • Drug Delivery
  • Prosthesis And Implants
  • Therapeutic System
  • Other Applications

7. High Performance Medical Plastics Market Regional And Country Analysis

  • 7.1. Global High Performance Medical Plastics Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 7.2. Global High Performance Medical Plastics Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific High Performance Medical Plastics Market

  • 8.1. Asia-Pacific High Performance Medical Plastics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific High Performance Medical Plastics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 8.3. Asia-Pacific High Performance Medical Plastics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China High Performance Medical Plastics Market

  • 9.1. China High Performance Medical Plastics Market Overview
  • 9.2. China High Performance Medical Plastics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
  • 9.3. China High Performance Medical Plastics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India High Performance Medical Plastics Market

  • 10.1. India High Performance Medical Plastics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 10.2. India High Performance Medical Plastics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan High Performance Medical Plastics Market

  • 11.1. Japan High Performance Medical Plastics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 11.2. Japan High Performance Medical Plastics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia High Performance Medical Plastics Market

  • 12.1. Australia High Performance Medical Plastics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 12.2. Australia High Performance Medical Plastics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia High Performance Medical Plastics Market

  • 13.1. Indonesia High Performance Medical Plastics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 13.2. Indonesia High Performance Medical Plastics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea High Performance Medical Plastics Market

  • 14.1. South Korea High Performance Medical Plastics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 14.2. South Korea High Performance Medical Plastics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe High Performance Medical Plastics Market

  • 15.1. Western Europe High Performance Medical Plastics Market Overview
  • 15.2. Western Europe High Performance Medical Plastics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 15.3. Western Europe High Performance Medical Plastics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK High Performance Medical Plastics Market

  • 16.1. UK High Performance Medical Plastics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 16.2. UK High Performance Medical Plastics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany High Performance Medical Plastics Market

  • 17.1. Germany High Performance Medical Plastics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 17.2. Germany High Performance Medical Plastics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France High Performance Medical Plastics Market

  • 18.1. France High Performance Medical Plastics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 18.2. France High Performance Medical Plastics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe High Performance Medical Plastics Market

  • 19.1. Eastern Europe High Performance Medical Plastics Market Overview
  • 19.2. Eastern Europe High Performance Medical Plastics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 19.3. Eastern Europe High Performance Medical Plastics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia High Performance Medical Plastics Market

  • 20.1. Russia High Performance Medical Plastics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 20.2. Russia High Performance Medical Plastics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America High Performance Medical Plastics Market

  • 21.1. North America High Performance Medical Plastics Market Overview
  • 21.2. North America High Performance Medical Plastics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 21.3. North America High Performance Medical Plastics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA High Performance Medical Plastics Market

  • 22.1. USA High Performance Medical Plastics Market Overview
  • 22.2. USA High Performance Medical Plastics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 22.3. USA High Performance Medical Plastics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America High Performance Medical Plastics Market

  • 23.1. South America High Performance Medical Plastics Market Overview
  • 23.2. South America High Performance Medical Plastics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 23.3. South America High Performance Medical Plastics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil High Performance Medical Plastics Market

  • 24.1. Brazil High Performance Medical Plastics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 24.2. Brazil High Performance Medical Plastics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East High Performance Medical Plastics Market

  • 25.1. Middle East High Performance Medical Plastics Market Overview
  • 25.2. Middle East High Performance Medical Plastics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 25.3. Middle East High Performance Medical Plastics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa High Performance Medical Plastics Market

  • 26.1. Africa High Performance Medical Plastics Market Overview
  • 26.2. Africa High Performance Medical Plastics Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 26.3. Africa High Performance Medical Plastics Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. High Performance Medical Plastics Market Competitive Landscape And Company Profiles

  • 27.1. High Performance Medical Plastics Market Competitive Landscape
  • 27.2. High Performance Medical Plastics Market Company Profiles
    • 27.2.1. Solvay SA
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. SABIC
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Mitsubishi Chemical Corporation
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Evonik Industries AG
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Arkema SA
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The High Performance Medical Plastics Market

29. High Performance Medical Plastics Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Historic And Forecast Inflation Rates
  • 30.4. Research Inquiries
  • 30.5. The Business Research Company
  • 30.6. Copyright And Disclaimer
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦